Baird’s Biotech Discovery Series, which launched in early 2022, is an opportunity for investors to hear directly from interesting and innovative public and private biotech companies in a fireside chat format. Each episode is centered around a key event for the focus company, which can include new clinical data, a material regulatory event, key management additions, a significant new investment, a key acquisition, new entry into the public markets, etc. 
 

Episode Thirty-One: Cellectis, Inc. (CLLS)

Wednesday, November 12, 2025 
10:30 A.M. ET (9:30 A.M. CT) ~45 minute duration

Guest Speakers: 

  • André Choulika, Ph. D., Chief Executive Officer 
  • Adrian Kilcoyne, MD, MPH, MBA, Chief Medical Officer

Hosted by Mike Perrone, CFA, Healthcare Specialist, Baird

Moderated by Jack Allen, CFA, Baird Senior Research Analyst, Biotechnology

Register here: https://goto.webcasts.com/starthere.jsp?ei=1741315&tp_key=dcd0ddb1f3